Sphingosine 1-phosphate: A Potential Molecular Target for Ovarian Cancer Therapy?

被引：30
|
作者：
Dai, Lan [1 ,2 ]
Xia, Pu [3 ]
Di, Wen [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Renji Hosp, Dept Obstet & Gynecol, Sch Med, Shanghai 200127, Peoples R China
[2] Fudan Univ, Focus Construct Subject Shanghai Educ Dept, Shanghai Key Lab Gynecol Oncol, Shanghai 200433, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Endocrinol, Shanghai 200433, Peoples R China
来源：
CANCER INVESTIGATION | 2014年 / 32卷 / 03期
关键词：
Ovarian cancer; Sphingosine; 1-phosphate; Sphingosine kinase; ENDOTHELIAL GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; NECROSIS-FACTOR-ALPHA; UP-REGULATION; TNF-ALPHA; KINASE; SPHINGOSINE-1-PHOSPHATE LYASE; SIGNALING PATHWAY; PROSTATE-CANCER; DOWN-REGULATION;
D O I：
10.3109/07357907.2013.876646
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Sphingosine 1-phosphate (S1P) is an important signaling regulator involved in tumor progression in multiple neoplasms. However, the role of S1P in the pathogenesis of ovarian cancer remains unclear. Herein, we summarize recent advances in understanding the impact of S1P signaling in ovarian cancer progression. S1P, aberrantly produced in ovarian cancer patients, is involved in the regulation of key cellular processes that contribute to ovarian cancer initiation and progression. Moreover, agents that block the S1P signaling pathway inhibit ovarian cancer cell growth or induce apoptosis. Hence, current evidence suggests that S1P may become a potential molecular target for ovarian cancer therapy.
引用
收藏
页码：71 / 80
页数：10
相关论文
共 50 条
  • [1] Sphingosine 1-phosphate as a therapeutic target in prostate cancer
    Cuvillier, O.
    BULLETIN DU CANCER, 2011, 98 : S56 - S56
  • [2] Sphingosine 1-phosphate, a potential target in neovascular retinal disease
    Alshaikh, Rasha A.
    Ryan, Katie B.
    Waeber, Christian
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2022, 106 (09) : 1187 - 1195
  • [3] Sphingosine 1-Phosphate Signaling as a Target in Hepatic Fibrosis Therapy
    Gonzalez-Fernandez, Barbara
    Sanchez, Diana I.
    Gonzalez-Gallego, Javier
    Tunon, Maria J.
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [4] Sphingosine 1-phosphate and cancer
    Nigel J. Pyne
    Susan Pyne
    Nature Reviews Cancer, 2010, 10 : 489 - 503
  • [5] Sphingosine 1-phosphate and cancer
    Pyne, Nigel J.
    Pyne, Susan
    NATURE REVIEWS CANCER, 2010, 10 (07) : 489 - 503
  • [6] Sphingosine kinase 1/sphingosine 1-phosphate/sphingosine 1-phosphate receptor 1 pathway: A novel target of geniposide to inhibit angiogenesis
    Sun, Minghui
    Deng, Ran
    Wang, Yan
    Wu, Hong
    Zhang, Zhengrong
    Bu, Yanhong
    Zhang, Heng
    LIFE SCIENCES, 2020, 256
  • [7] Sphingosine 1-phosphate signalling in cancer
    Pyne, Nigel J.
    Tonelli, Francesca
    Lim, Keng Gat
    Long, Jaclyn S.
    Edwards, Joanne
    Pyne, Susan
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 94 - 100
  • [8] The role of sphingosine 1-phosphate in cancer
    Pyne, Susan
    Ohotski, Jan
    Cochrane, Stuart
    Tonelli, Francesca
    Lim, Keng Gat
    Bittman, Robert
    Edwards, Joanne
    Pyne, Nigel J.
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 : S33 - S33
  • [9] Sphingosine kinase 1/sphingosine 1-phosphate signalling pathway as a potential therapeutic target of pulmonary hypertension
    Xing, Xi-Qian
    Li, Yan-Li
    Zhang, Yu-Xuan
    Xiao, Yi
    Li, Zhi-Dong
    Liu, Li-Qiong
    Zhou, Yu-Shan
    Zhang, Hong-Yan
    Liu, Yan-Hong
    Zhang, Li-Hui
    Zhuang, Min
    Chen, Yan-Ping
    Ouyang, Sheng-Rong
    Wu, Xu-Wei
    Yang, Jiao
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (08): : 11930 - 11935
  • [10] Targeting sphingosine 1-phosphate and sphingosine kinases in pancreatic cancer: mechanisms and therapeutic potential
    Limbu, Khem Raj
    Chhetri, Rashmi Bhandari
    Kim, Subin
    Shrestha, Jitendra
    Oh, Yoon Sin
    Baek, Dong Jae
    Park, Eun-Young
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
12345